Drug Trial Radar · NCT07449702
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
Last checked: Nov 20, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
240
Planned (sponsor's estimate)
Start
Feb 23, 2026
Primary completion
May 2030
Study completion Jul 2030
Sponsor
- Lead sponsor
- Oruka Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Mar 4, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
An open-label extension (OLE) study to evaluate the long-term safety and efficacy of ORKA-001 in adult participants with moderate-to-severe plaque psoriasis, who previously participated in an Oruka Therapeutics sponsored study.
Conditions
- Plaque Psoriasis
Interventions
ORKA-001Drug
ORKA-001 administered by subcutaneous (SC) injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Treatment-emergent Adverse Events (TEAEs), Treatment-emergent Serious Adverse Events (TESAEs), and TEAEs of Special Interest (TEAESIs)Time frame: Day 1 through Week 144
Locations
39 sites in 2 countries. Site status is shown where the registry gives one.
Oruka Therapeutics Investigative Site
Phoenix, Arizona · Recruiting
Oruka Therapeutics Investigative Site
North Little Rock, Arkansas · Recruiting
Oruka Therapeutics Investigative Site
Fountain Valley, California · Recruiting
Oruka Therapeutics Investigative Site
Los Angeles, California · Recruiting
Oruka Therapeutics Investigative Site
Los Angeles, California · Recruiting
Oruka Therapeutics Investigative Site
San Diego, California · Recruiting
Oruka Therapeutics Investigative Site
Santa Ana, California · Recruiting
Oruka Therapeutics Investigative Site
Santa Monica, California · Recruiting
Oruka Therapeutics Investigative Site
Cromwell, Connecticut · Recruiting
Oruka Therapeutics Investigative Site
Miami, Florida · Recruiting
Oruka Therapeutics Investigative Site
Rolling Meadows, Illinois · Recruiting
Oruka Therapeutics Investigative Site
Plainfield, Indiana · Recruiting
Oruka Therapeutics Investigative Site
Bowling Green, Kentucky · Recruiting
Oruka Therapeutics Investigative Site
Rockville, Maryland · Recruiting
Oruka Therapeutics Investigative Site
Boston, Massachusetts · Recruiting
Oruka Therapeutics Investigative Site
Detroit, Michigan · Recruiting
Oruka Therapeutics Investigative Site
New York, New York · Recruiting
Oruka Therapeutics Investigative Site
New York, New York · Recruiting
Oruka Therapeutics Investigative Site
Cleveland, Ohio · Recruiting
Oruka Therapeutics Investigative Site
Mason, Ohio · Recruiting
Oruka Therapeutics Investigative Site
Portland, Oregon · Recruiting
Oruka Therapeutics Investigative Site
Portland, Oregon · Recruiting
Oruka Therapeutics Investigative Site
Frisco, Texas · Recruiting
Oruka Therapeutics Investigative Site
Houston, Texas · Recruiting
Oruka Therapeutics Investigative Site
Webster, Texas · Recruiting
Oruka Therapeutics Investigative Site
Norfolk, Virginia · Recruiting
Oruka Therapeutics Investigative Site
Edmonton, Alberta, Canada · Recruiting
Oruka Therapeutics Investigative Site
Edmonton, Alberta, Canada · Recruiting
Oruka Therapeutics Investigative Site
Surrey, British Columbia, Canada · Recruiting
Oruka Therapeutics Investigative Site
Surrey, British Columbia, Canada · Recruiting
Oruka Therapeutics Investigative Site
Fredericton, New Brunswick, Canada · Recruiting
Oruka Therapeutics Investigative Site
Ajax, Ontario, Canada · Recruiting
Oruka Therapeutics Investigative Site
London, Ontario, Canada · Recruiting
Oruka Therapeutics Investigative Site
Markham, Ontario, Canada · Recruiting
Oruka Therapeutics Investigative Site
Peterborough, Ontario, Canada · Recruiting
Oruka Therapeutics Investigative Site
Toronto, Ontario, Canada · Recruiting
Oruka Therapeutics Investigative Site
Waterloo, Ontario, Canada · Recruiting
Oruka Therapeutics Investigative Site
Montreal, Quebec, Canada · Recruiting
Oruka Therapeutics Investigative Site
Québec, Quebec, Canada · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.